Results 171 to 180 of about 8,519 (204)

PRMT5 INHIBITORS

2021
MACHACEK MICHELLE, ALTMAN MICHAEL, HUANG CHUNHUI, REUTERSHAN MICHAEL, SLOMAN DAVID, WITTER DAVID, GIBEAU CRAIG   +6 more
openaire   +3 more sources

PRMT5 inhibitors

2019
MACHACEK MICHELLE, WITTER DAVID, REUTERSHAN MICHAEL HALE, SLOMAN DAVID, ALTMAN MICHAEL   +4 more
openaire   +5 more sources

PRMT5 Regulates RNA m6A Demethylation for Doxorubicin Sensitivity in Breast Cancer

Molecular Therapy, 2022
Ceshi Chen, Changhong Shi
exaly  

Anti-Tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes With PRMT5 Inhibition Through MTAP Loss

Cancer Cell, 2019
Michael T McCabe, Olena Barbash, Nigel J. Waters   +2 more
exaly  

PRMT5 inhibitors

2023
BOOKER SHON, BOURBEAU MATTHEW PAUL, BUTLER JOHN R, GLAD SANNE ORMHOLT SCHRODER, LANMAN BRIAN ALAN, LOPEZ PATRICIA, MANONI FRANCESCO, PETTUS LIPING H, SARVARY IAN, TAMAYO NURIA A, VESTERGAARD MIKKEL, WEIRES NICHOLAS ANTHONY   +11 more
openaire   +1 more source

TETRAHYDROISOQUINOLINES AS PRMT5 INHIBITORS

2017
BERGMAN YLVA ELISABET, CAMERINO MICHELLE ANG, WALKER SCOTT RAYMOND, STUPPLE PAUL ANTHONY   +3 more
openaire   +7 more sources

PRMT5 Restricts ERK Activity

Nature Reviews Molecular Cell Biology, 2011
Katharine Wrighton
exaly  

COMPOUNDS TARGETING PRMT5

2020
VANDYCK KOEN, RABOISSON PIERRE JEAN-MARIE BERNARD, DEVAL JEROME, BEIGELMAN LEONID, MCGOWAN DAVID, DEBING YANNICK   +5 more
openaire   +2 more sources

PRMT5 INHIBITORS

2022
MACHACEK MICHELLE, ALTMAN MICHAEL D, HUANG CHUNHUI, REUTERSHAN MICHAEL H, SLOMAN DAVID L, SILIPHAIVANH PHIENG, SCHNEIDER SEBASTIAN E, YEUNG CHARLES S, WITTER DAVID J, GIBEAU CRAIG R, YE YINGCHUN   +10 more
openaire   +2 more sources

Low Levels of miR‐92b/96 Induce PRMT5 Translation and H3R8/H4R3 Methylation in Mantle Cell Lymphoma

EMBO Journal, 2007
Saïd Sif, John C. Byrd, Michael R Grever   +2 more
exaly